Zero-order controlled release of ciprofloxacin-HCl from a reservoir-based, bioresorbable and elastomeric device
Name
Cima_Zero-order controlled.pdf
Size
1.41 MB
Format
Adobe PDF
Checksum (MD5)
0d4b29a805e919575b0ba3e52711e550
Author(s)
Tobias, Irene S.
Lee, Heejin
Macaya, Daniel
Bettinger, Christopher J.
Cima, Michael J.
Engelmayr, George C., Jr.
Date Issued
June 2010
Journal
Journal of Controlled Release
Publisher
Elsevier
Citation
Tobias, Irene S., Heejin Lee, George C. Engelmayr Jr., Daniel Macaya, Christopher J. Bettinger, and Michael J. Cima. “Zero-Order Controlled Release of Ciprofloxacin-HCl from a Reservoir-Based, Bioresorbable and Elastomeric Device.” Journal of Controlled Release 146, no. 3 (September 15, 2010): 356–362.
Version
Author's final manuscript
Abstract
A reservoir-based device constructed of a completely biodegradable elastomer can enable several new implantation and insertion options for localized drug therapy, particularly in the case of urological therapies. We performed an in vitro performance evaluation of an implantable, bio-resorbable device that supplies short-term controlled release of ciprofloxacin-HCl (CIP). The proposed device functions through a combination of osmosis and diffusion mechanisms to release CIP for short-term therapies of a few weeks duration. Poly(glycerol-co-sebacic acid) (PGS) was cast in a tubular geometry with solid drug powder packed into its core and a micro-machined release orifice drilled through its wall. Drug release experiments were performed to determine the effective release rate from a single orifice and the range of orifice sizes in which controlled zero-order release was the main form of drug expulsion from the device. It is demonstrated that PGS is sufficiently permeable to water to allow the design of an elementary osmotic pump for drug delivery. Indeed, PGS's water permeability is several orders of magnitude larger than commonly used cellulose acetate for elementary osmotic pumps.
MIT Department
Massachusetts Institute of Technology. Materials Processing Center
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Materials Science and Engineering
Massachusetts Institute of Technology. Department of Mechanical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-NoDerivatives
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.jconrel.2010.05.036
